Summary of thirteen patients acquired resistance to erlotinib.
收藏数据链接：
官方服务：
资源简介：
Time on erlotinib*, Time to progression after erlotinib therapy; Response#, Response to erlotinib; del,deletion; Adeno, adenocarcinoma. CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease.
创建时间：
2015-12-02
